Filing Details

Accession Number:
0000950170-24-058720
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-13 16:36:00
Reporting Period:
2024-05-10
Accepted Time:
2024-05-13 16:36:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397513 David Kroin C/O Deep Track Capital, Lp,
200 Greenwich Ave, 3Rd Floor
Greenwich CT 06830
No No No No
1856083 Deep Track Capital, Lp 200 Greenwich Ave, 3Rd Floor
Greenwich CT 06830
No No No No
2015536 Deep Track Biotechnology Master Fund, Ltd. C/O Walkers Corporate Limited
190 Elgin Ave, George Town
Ky1-9001 E9 0000
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-10 56,000 $1.78 18,344,000 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.745 to $1.81, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
  2. Represents securities held by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, LP. is the investment manager of Deep Track Biotechnology Master Fund, Ltd. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, L.P. and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests.